New drug combo shows promise for Hard-to-Treat cancers
NCT ID NCT07169994
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a new drug called YL202 combined with other anti-cancer medicines (toripalimab or furmonertinib) in people with advanced solid tumors, including breast and lung cancer. The goal is to find safe doses and see if the combination shrinks tumors. About 414 adults aged 18-75 who have tried standard treatments are being recruited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
YL202 (a drug) combined with toripalimab or furmonertinib mesilate
What this could lead to
If successful, this could point toward a new treatment option for people with advanced solid tumors that have not responded to standard therapies.
What could go wrong
This is an early-phase trial (phase Ib/II) with a small number of participants, so the safety and effectiveness are not yet proven. There is a risk of side effects, and the combination may not work for all tumor types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital Of Hebei University
NOT_YET_RECRUITINGBaoding, Hebei, 71051, China
Contact
-
Affiliated Zhongshan Hospital Dalian University
NOT_YET_RECRUITINGDalian, Liaoning, 116001, China
Contact
-
Affiliated Zhongshan Hospital Dalian University
NOT_YET_RECRUITINGJinan, Shandong, 250117, China
Contact
-
Anhui Provincial Hospital(The First Affiliated Hospital of Ustc)
NOT_YET_RECRUITINGHefei, Anhui, 230001, China
Contact
-
Anyang Cancer Hospital
NOT_YET_RECRUITINGAnyang, Henan, 455100, China
Contact
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 201321, China
Contact
-
Fujian Cancer Hospital
NOT_YET_RECRUITINGFuzhou, Fujian, 350014, China
Contact
-
Ghang xi Medical University Cancer Hospital
NOT_YET_RECRUITINGNanning, Guangxi, 530028, China
Contact
-
Harbin Medical University Cancer Hospital
NOT_YET_RECRUITINGHarbin, Heilongjiang, 150081, China
Contact
-
Jiangsu Province Hospital（The First Affiliated Hospital With Nanjing Medical University, Jiangsu Women And Children Health Hospital)
NOT_YET_RECRUITINGNanjing, Jiangsu, 210029, China
Contact
-
Jiangxi Cancer Hospital
NOT_YET_RECRUITINGNanchang, Jiangxi, China
Contact
-
Liaoning cancer hospital &institute
NOT_YET_RECRUITINGShenyang, Liaoning, 110042, China
Contact
-
Meizhou People's Hospital（Huangtang Hospital）Meizhou Academy of Medical Sciences
NOT_YET_RECRUITINGMeizhou, Guangdong, 514031, China
Contact
-
Shanxi Cancer Hospital
NOT_YET_RECRUITINGTaiyuan, Shanxi, 30013, China
Contact
-
Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital
NOT_YET_RECRUITINGSichuan, Sichuan, 610072, China
Contact
-
Sun Yat-sen University Cancer Center
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510555, China
Contact
-
The First Affiliated Hospital of Henan University of Science and Technology
NOT_YET_RECRUITINGLuoyang, Henan, 471023, China
Contact
-
The First People's Hospital of Changde City
NOT_YET_RECRUITINGChangde, Hunan, 415000, China
Contact
-
Tianjin Cancer Hospital Airport Hospital
NOT_YET_RECRUITINGTianjin, Tianjin Municipality, 300300, China
Contact
-
Xiangyang Central Hospital
NOT_YET_RECRUITINGXiangyang, Hubei, 441138, China
Contact